Isabel Marugán

1.4k total citations
29 papers, 620 citations indexed

About

Isabel Marugán is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Isabel Marugán has authored 29 papers receiving a total of 620 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 12 papers in Genetics and 12 papers in Pathology and Forensic Medicine. Recurrent topics in Isabel Marugán's work include Chronic Lymphocytic Leukemia Research (10 papers), Lymphoma Diagnosis and Treatment (10 papers) and Acute Myeloid Leukemia Research (6 papers). Isabel Marugán is often cited by papers focused on Chronic Lymphocytic Leukemia Research (10 papers), Lymphoma Diagnosis and Treatment (10 papers) and Acute Myeloid Leukemia Research (6 papers). Isabel Marugán collaborates with scholars based in Spain, United States and Germany. Isabel Marugán's co-authors include J Garcı́a-Conde, Felipe Prósper, Aňa Lluch, Ángel Martínez-Agulló, Amelia Insa, Isabel Benet, Mar Tormo, José A. Martínez-Climent, María José Terol and Carlos Solano and has published in prestigious journals such as Blood, Cancer and Annals of Oncology.

In The Last Decade

Isabel Marugán

29 papers receiving 603 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Isabel Marugán Spain 15 273 177 177 153 150 29 620
A. M. Gianni Italy 15 294 1.1× 109 0.6× 201 1.1× 83 0.5× 95 0.6× 26 619
Carlos E. Vigil United States 14 256 0.9× 254 1.4× 117 0.7× 144 0.9× 113 0.8× 47 785
I. Quiquandon France 12 276 1.0× 226 1.3× 193 1.1× 210 1.4× 89 0.6× 17 774
MY Mapara Germany 10 443 1.6× 150 0.8× 444 2.5× 131 0.9× 158 1.1× 11 795
Gregg A. Olsen United States 11 417 1.5× 79 0.4× 205 1.2× 61 0.4× 133 0.9× 17 752
Tomáš Papajík Czechia 16 265 1.0× 158 0.9× 383 2.2× 316 2.1× 97 0.6× 109 792
Paolo Fiumara Italy 12 282 1.0× 196 1.1× 303 1.7× 140 0.9× 72 0.5× 28 684
E. Wunder France 11 306 1.1× 147 0.8× 61 0.3× 98 0.6× 202 1.3× 28 696
María Laura Gutiérrez Spain 15 195 0.7× 145 0.8× 182 1.0× 96 0.6× 167 1.1× 30 496
T.E. Witzig United States 9 416 1.5× 200 1.1× 388 2.2× 162 1.1× 84 0.6× 18 778

Countries citing papers authored by Isabel Marugán

Since Specialization
Citations

This map shows the geographic impact of Isabel Marugán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabel Marugán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabel Marugán more than expected).

Fields of papers citing papers by Isabel Marugán

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabel Marugán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabel Marugán. The network helps show where Isabel Marugán may publish in the future.

Co-authorship network of co-authors of Isabel Marugán

This figure shows the co-authorship network connecting the top 25 collaborators of Isabel Marugán. A scholar is included among the top collaborators of Isabel Marugán based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabel Marugán. Isabel Marugán is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
González-Gascón-y-Marín, Isabel, María Hernández‐Sánchez, Carmen Sanzo, et al.. (2015). A high proportion of cells carrying trisomy 12 is associated with a worse outcome in patients with chronic lymphocytic leukemia. Hematological Oncology. 34(2). 84–92. 19 indexed citations
2.
Guillem, Vicent, Paula Amat, Francisco Cervantes, et al.. (2011). Functional polymorphisms in SOCS1 and PTPN22 genes correlate with the response to imatinib treatment in newly diagnosed chronic-phase chronic myeloid leukemia. Leukemia Research. 36(2). 174–181. 18 indexed citations
3.
Tormo, Mar, Isabel Marugán, & Marisa Calabuig. (2010). Myelodysplastic syndromes: an update on molecular pathology. Clinical & Translational Oncology. 12(10). 652–661. 14 indexed citations
4.
Guillem, Vicent, Francisco Cervantes, Jesús Martı́nez, et al.. (2010). XPC genetic polymorphisms correlate with the response to imatinib treatment in patients with chronic phase chronic myeloid leukemia. American Journal of Hematology. 85(7). 482–486. 24 indexed citations
5.
Cabezudo, Maria-Elena, Javier López‐Jiménez, Isabel Marugán, et al.. (2009). Immune Reconstitution Of Regulatory T-Cells Following Autologous Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 15(2). 140–140. 4 indexed citations
6.
Ramı́rez, Manuel, et al.. (2004). Engraftment kinetics of human CD34+ cells from cord blood and mobilized peripheral blood co-transplanted into NOD/SCID mice. Bone Marrow Transplantation. 35(3). 271–275. 9 indexed citations
7.
Marugán, Isabel, Isabel Benet, María José Terol, et al.. (2004). Bcl-6 mutation status provides clinically valuable information in early-stage B-cell chronic lymphocytic leukemia. Leukemia. 18(4). 743–746. 14 indexed citations
8.
Terol, María José, Mar Tormo, José A. Martínez-Climent, et al.. (2003). Soluble intercellular adhesion molecule-1 (s-ICAM-1/s-CD54) in diffuse large B-cell lymphoma: association with clinical characteristics and outcome. Annals of Oncology. 14(3). 467–474. 24 indexed citations
9.
Martínez-Climent, José A., Dolors Sánchez-Izquierdo, David Blesa, et al.. (2003). Genomic Abnormalities Acquired in the Blastic Transformation of Splenic Marginal Zone B-cell Lymphoma. Leukemia & lymphoma. 44(3). 459–464. 15 indexed citations
10.
Gutiérrez, Antonio, Carlos Solano, Isabel Benet, et al.. (2003). Reconstitution of lymphocyte populations and cytomegalovirus viremia or disease after allogeneic peripheral blood stem cell transplantation. Journal of Medical Virology. 70(3). 399–403. 10 indexed citations
11.
Solano, Carlos, Antonio Ferrández, Isabel Marugán, et al.. (2003). Peripheral T‐cell lymphoma associated consecutively with hemophagocytic lymphohistiocytosis and hypereosinophilic syndrome. European Journal Of Haematology. 71(4). 303–306. 13 indexed citations
12.
Martínez-Climent, José A., Isabel Benet, Isabel Marugán, et al.. (2001). Identification of two subgroups of mantle cell leukemia with distinct clinical and biological features. The Hematology Journal. 2(4). 234–241. 15 indexed citations
13.
14.
Sánchez-Izquierdo, Dolors, Reiner Siebert, Lana Harder, et al.. (2001). Detection of translocations affecting the BCL6 locus in B cell non-Hodgkin's lymphoma by interphase fluorescence in situ hybridization. Leukemia. 15(9). 1475–1484. 41 indexed citations
15.
Martínez-Climent, José A., Isabel Benet, Cristina Arbona, et al.. (2000). Chromosomal abnormalities in women with breast cancer after autologous stem cell transplantation are infrequent and may not predict development of therapy-related leukemia or myelodysplastic syndrome. Bone Marrow Transplantation. 25(11). 1203–1208. 13 indexed citations
16.
Juan, Óscar, Aňa Lluch, Felipe Prósper, et al.. (1999). Prognostic factors in patients with isolated recurrences of breast cancer (stage IV-NED). Breast Cancer Research and Treatment. 53(2). 105–112. 18 indexed citations
17.
Benet, Isabel, Felipe Prósper, Isabel Marugán, et al.. (1999). Mobilization of peripheral blood progenitor cells (PBPC) in patients undergoing chemotherapy followed by autologous peripheral blood stem cell transplant (SCT) for high risk breast cancer (HRBC). Bone Marrow Transplantation. 23(11). 1101–1107. 5 indexed citations
18.
Insa, Amelia, Aňa Lluch, Felipe Prósper, et al.. (1999). Prognostic factors predicting survival from first recurrence in patients with metastatic breast cancer: analysis of 439 patients. Breast Cancer Research and Treatment. 56(1). 67–78. 147 indexed citations
19.
Bolufer, Pascual, Eva Barragán, Miguel Á. Sanz, et al.. (1998). Preliminary experience in external quality control of RT-PCR PML-RARα detection in promyelocytic leukemia. Leukemia. 12(12). 2024–2028. 21 indexed citations
20.
Ruiz, Maria Armila, Isabel Marugán, A. Estellés, et al.. (1989). The influence of chemotherapy on plasma coagulation and fibrinolytic systems in lung cancer patients. Cancer. 63(4). 643–648. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. M. Gianni Breakdown of academic impact, for papers by Carlos E. Vigil Breakdown of academic impact, for papers by I. Quiquandon Breakdown of academic impact, for papers by MY Mapara Breakdown of academic impact, for papers by Gregg A. Olsen Breakdown of academic impact, for papers by Tomáš Papajík Breakdown of academic impact, for papers by Paolo Fiumara Breakdown of academic impact, for papers by E. Wunder Breakdown of academic impact, for papers by María Laura Gutiérrez Breakdown of academic impact, for papers by T.E. Witzig
Rankless by CCL
2026